FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213288097> ?p ?o ?g. }

• W4213288097 endingPage "2339" @default.
• W4213288097 startingPage "2325" @default.
• W4213288097 abstract "Pulmonary hypertension (PH) is a cardiopulmonary disease characterized by a progressive increase in pulmonary vascular resistance. One of the initial pathogenic factors of PH is pulmonary arterial remodeling under various stimuli. Current marketed drugs against PH mainly relieve symptoms without significant improvement in overall prognosis. Discovering and developing new therapeutic drugs that interfere with vascular remodeling is in urgent need. Puerarin is an isoflavone compound extracted from the root of Kudzu vine, which is widely used in the treatment of cardiovascular diseases. In the present study, we evaluated the efficacy of puerarin in the treatment of experimental PH. PH was induced in rats by a single injection of MCT (50 mg/kg, sc), and in mice by exposure to hypoxia (10% O2) for 14 days. After MCT injection the rats were administered puerarin (10, 30, 100 mg · kg−1 · d−1, i.g.) for 28 days, whereas hypoxia-treated mice were pre-administered puerarin (60 mg · kg−1 · d−1, i.g.) for 7 days. We showed that puerarin administration exerted significant protective effects in both experimental PH rodent models, evidenced by significantly reduced right ventricular systolic pressure (RVSP) and lung injury, improved pulmonary artery blood flow as well as pulmonary vasodilation and contraction function, inhibited inflammatory responses in lung tissues, improved resistance to apoptosis and abnormal proliferation in lung tissues, attenuated right ventricular injury and remodeling, and maintained normal function of the right ventricle. We revealed that MCT and hypoxia treatment significantly downregulated BMPR2/Smad signaling in the lung tissues and PPARγ/PI3K/Akt signaling in the lung tissues and right ventricles, which were restored by puerarin administration. In addition, we showed that a novel crystal type V (Puer-V) exerted better therapeutic effects than the crude form of puerarin (Puer). Furthermore, Puer-V was more efficient than bosentan (a positive control drug) in alleviating the abnormal structural changes and dysfunction of lung tissues and right ventricles. In conclusion, this study provides experimental evidence for developing Puer-V as a novel therapeutic drug to treat PH." @default.
• W4213288097 created "2022-02-24" @default.
• W4213288097 creator A5007063042 @default.
• W4213288097 creator A5010710324 @default.
• W4213288097 creator A5030399311 @default.
• W4213288097 creator A5033484403 @default.
• W4213288097 creator A5033681865 @default.
• W4213288097 creator A5050720861 @default.
• W4213288097 creator A5061928767 @default.
• W4213288097 creator A5071698217 @default.
• W4213288097 creator A5073524724 @default.
• W4213288097 date "2022-02-21" @default.
• W4213288097 modified "2023-10-18" @default.
• W4213288097 title "Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models" @default.
• W4213288097 cites W1526976168 @default.
• W4213288097 cites W1799342040 @default.
• W4213288097 cites W1976735273 @default.
• W4213288097 cites W1996842940 @default.
• W4213288097 cites W2018303299 @default.
• W4213288097 cites W2030346943 @default.
• W4213288097 cites W2084064095 @default.
• W4213288097 cites W2086242101 @default.
• W4213288097 cites W2090742340 @default.
• W4213288097 cites W2100425308 @default.
• W4213288097 cites W2111397592 @default.
• W4213288097 cites W2130290719 @default.
• W4213288097 cites W2166224440 @default.
• W4213288097 cites W2210270565 @default.
• W4213288097 cites W2397103006 @default.
• W4213288097 cites W2582627120 @default.
• W4213288097 cites W2611097527 @default.
• W4213288097 cites W2621496307 @default.
• W4213288097 cites W2754689599 @default.
• W4213288097 cites W2767924566 @default.
• W4213288097 cites W2771450355 @default.
• W4213288097 cites W2775557020 @default.
• W4213288097 cites W2801247219 @default.
• W4213288097 cites W2900537098 @default.
• W4213288097 cites W2901328677 @default.
• W4213288097 cites W2903687370 @default.
• W4213288097 cites W2904180601 @default.
• W4213288097 cites W2906059785 @default.
• W4213288097 cites W2944324656 @default.
• W4213288097 cites W2953466278 @default.
• W4213288097 cites W2955467892 @default.
• W4213288097 cites W2974957568 @default.
• W4213288097 cites W2977796345 @default.
• W4213288097 cites W3004500622 @default.
• W4213288097 cites W3008079761 @default.
• W4213288097 cites W3032668946 @default.
• W4213288097 cites W3044391773 @default.
• W4213288097 cites W3096046625 @default.
• W4213288097 cites W3096737466 @default.
• W4213288097 cites W3098511521 @default.
• W4213288097 cites W3110053993 @default.
• W4213288097 cites W3111447194 @default.
• W4213288097 cites W3119183811 @default.
• W4213288097 cites W3121899351 @default.
• W4213288097 cites W3135899205 @default.
• W4213288097 cites W3154340860 @default.
• W4213288097 cites W3156865634 @default.
• W4213288097 cites W3158257231 @default.
• W4213288097 cites W3171148573 @default.
• W4213288097 cites W3190325424 @default.
• W4213288097 cites W4205424893 @default.
• W4213288097 cites W4245490992 @default.
• W4213288097 doi "https://doi.org/10.1038/s41401-022-00865-y" @default.
• W4213288097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35190697" @default.
• W4213288097 hasPublicationYear "2022" @default.
• W4213288097 type Work @default.
• W4213288097 citedByCount "5" @default.
• W4213288097 countsByYear W42132880972022 @default.
• W4213288097 countsByYear W42132880972023 @default.
• W4213288097 crossrefType "journal-article" @default.
• W4213288097 hasAuthorship W4213288097A5007063042 @default.
• W4213288097 hasAuthorship W4213288097A5010710324 @default.
• W4213288097 hasAuthorship W4213288097A5030399311 @default.
• W4213288097 hasAuthorship W4213288097A5033484403 @default.
• W4213288097 hasAuthorship W4213288097A5033681865 @default.
• W4213288097 hasAuthorship W4213288097A5050720861 @default.
• W4213288097 hasAuthorship W4213288097A5061928767 @default.
• W4213288097 hasAuthorship W4213288097A5071698217 @default.
• W4213288097 hasAuthorship W4213288097A5073524724 @default.
• W4213288097 hasBestOaLocation W42132880971 @default.
• W4213288097 hasConcept C126322002 @default.
• W4213288097 hasConcept C142724271 @default.
• W4213288097 hasConcept C164705383 @default.
• W4213288097 hasConcept C178790620 @default.
• W4213288097 hasConcept C178853913 @default.
• W4213288097 hasConcept C185592680 @default.
• W4213288097 hasConcept C204787440 @default.
• W4213288097 hasConcept C2776780178 @default.
• W4213288097 hasConcept C2777714996 @default.
• W4213288097 hasConcept C2778356392 @default.
• W4213288097 hasConcept C2778921608 @default.
• W4213288097 hasConcept C2780930700 @default.
• W4213288097 hasConcept C2780940725 @default.
• W4213288097 hasConcept C540031477 @default.

• next